Stay updated on GVAX & Pembrolizumab in MMR-p CRC Clinical Trial

Sign up to get notified when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-28T15:35:38.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A site-wide banner announces an NIH terminology transition, stating that agencies are using “Super Intelligence” in place of “Artificial Intelligence” and linking to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-21T19:44:05.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page, with its displayed site revision updated from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-14T18:58:08.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now displays site revision v3.7.1 instead of v3.7.0, while the study page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T20:18:18.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error with a minimal header and navigation. It replaces the usual study content, indicating that access to the study details is blocked.
    Difference
    19%
    Check dated 2026-09-23T20:34:48.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0. This indicates a refresh or minor update to the page content.
    Difference
    0.1%
    Check dated 2026-09-16T21:40:44.000Z thumbnail image

Stay in the know with updates to GVAX & Pembrolizumab in MMR-p CRC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GVAX & Pembrolizumab in MMR-p CRC Clinical Trial page.